Activin A and Glucose Derived Human Pancreatic Ductal Cells into Insulin-producing Cells

2007 ◽  
Vol 31 (1) ◽  
pp. 44
Author(s):  
Seung Hyun Hong ◽  
Chul Han ◽  
Hyo Sup Kim ◽  
Mi Kyung Park ◽  
Young Jin Lee ◽  
...  
2013 ◽  
Vol 217 (3) ◽  
pp. 241-252 ◽  
Author(s):  
Hyo-Sup Kim ◽  
Seung-Hyun Hong ◽  
Seung-Hoon Oh ◽  
Jae-Hyeon Kim ◽  
Myung-Shik Lee ◽  
...  

Islet transplantation is one treatment option for diabetes mellitus. However, novel sources of pancreatic islets or insulin-producing cells are required because the amount of donor tissue available is severely limited. Pancreatic ductal cells are an alternative source of β-cells because they have the potential to differentiate into insulin-producing cells. We investigated whether treatment of human pancreatic ductal cells with activin A (ActA) and exendin-4 (EX-4) stimulated transdifferentiation of the cells, bothin vitroandin vivo. We treated human pancreatic ductal cells with ActA and EX-4 in high-glucose media to induce differentiation into insulin-producing cells and transplanted the cells into streptozotocin-induced diabetic nude mice. Co-treatment of mice with ActA and EX-4 promoted cell proliferation, induced expression of pancreatic β-cell-specific markers, and caused glucose-induced insulin secretion compared with the ActA or EX-4 mono-treatment groups respectively. When pancreatic ductal cells treated with ActA and EX-4 in high-glucose media were transplanted into diabetic nude mice, their blood glucose levels normalized and insulin was detected in the graft. These findings suggest that pancreatic ductal cells have a potential to replace pancreatic islets for the treatment of diabetes mellitus when the ductal cells are co-treated with ActA, EX-4, and glucose to promote their differentiation into functional insulin-producing cells.


2019 ◽  
Vol 14 (1) ◽  
pp. 65-74 ◽  
Author(s):  
Aravinth P. Jawahar ◽  
Siddharth Narayanan ◽  
Gopalakrishnan Loganathan ◽  
Jithu Pradeep ◽  
Gary C. Vitale ◽  
...  

Islet cell auto-transplantation is a novel strategy for maintaining blood glucose levels and improving the quality of life in patients with chronic pancreatitis (CP). Despite the many recent advances associated with this therapy, obtaining a good yield of islet infusate still remains a pressing challenge. Reprogramming technology, by making use of the pancreatic exocrine compartment, can open the possibility of generating novel insulin-producing cells. Several lineage-tracing studies present evidence that exocrine cells undergo dedifferentiation into a progenitor-like state from which they can be manipulated to form insulin-producing cells. This review will present an overview of recent reports that demonstrate the potential of utilizing pancreatic ductal cells (PDCs) for reprogramming into insulin- producing cells, focusing on the recent advances and the conflicting views. A large pool of ductal cells is released along with islets during the human islet isolation process, but these cells are separated from the pure islets during the purification process. By identifying and improving existing ductal cell culture methods and developing a better understanding of mechanisms by which these cells can be manipulated to form hormone-producing islet-like cells, PDCs could prove to be a strong clinical tool in providing an alternative beta cell source, thus helping CP patients maintain their long-term glucose levels.


2007 ◽  
Vol 83 (7) ◽  
pp. 925-930 ◽  
Author(s):  
Mi-Kyung Park ◽  
Chul Han ◽  
Kyung-Hee Lee ◽  
Seung-Hyun Hong ◽  
Hyo Sup Kim ◽  
...  

Viruses ◽  
2019 ◽  
Vol 11 (7) ◽  
pp. 597 ◽  
Author(s):  
Antoine Bertin ◽  
Famara Sane ◽  
Valery Gmyr ◽  
Delphine Lobert ◽  
Arthur Dechaumes ◽  
...  

Coxsackievirus-B4 (CV-B4) E2 can persist in the pancreatic ductal-like cells (Panc-1 cell line), which results in an impaired differentiation of these cells into islet-like cell aggregates (ICA). In this study, primary pancreatic ductal cells obtained as a by-product of islet isolation from the pancreas of seven brain-dead adults were inoculated with CV-B4 E2, followed-up for 29 days, and the impact was investigated. Viral titers in culture supernatants were analyzed throughout the culture. Intracellular viral RNA was detected by RT-PCR. Levels of ductal cell marker CK19 mRNA and of insulin mRNA were evaluated by qRT-PCR. The concentration of c-peptide in supernatants was determined by ELISA. Ductal cells exposed to trypsin and serum-free medium formed ICA and resulted in an increased insulin secretion. Ductal cells from five brain-dead donors were severely damaged by CV-B4 E2, whereas the virus persisted in cultures of cells obtained from the other two. The ICAs whose formation was induced on day 14 post-inoculation were scarce and appeared tiny in infected cultures. Also, insulin mRNA expression and c-peptide levels were strongly reduced compared to the controls. In conclusion, CV-B4 E2 lysed human primary pancreatic ductal cells or persisted in these cells, which resulted in the impairment of differentiation into insulin-producing cells.


2005 ◽  
Vol 333 (4) ◽  
pp. 1153-1159 ◽  
Author(s):  
Ghaffar Muharram ◽  
Anthony Beucher ◽  
Ericka Moerman ◽  
Sandrine Belaı¨ch ◽  
Valéry Gmyr ◽  
...  

2021 ◽  
Author(s):  
J Krüger ◽  
M Breunig ◽  
T Seufferlein ◽  
M Hohwieler ◽  
A Kleger

Sign in / Sign up

Export Citation Format

Share Document